Swedish injection moulder Nolato (Torekov; www.nolato.se) has reported a 21% year-on-year increase in operating profit (EBITA) to SEK 570m (EUR 60.5m) in 2015. Sales in the year rose by 12% to SEK 4.73 bn. Hans Porat, Nolato president and CEO, said: “For the fourth consecutive year, this is the best operating profit in the group’s history. In 2015, we have continued according to our established strategy of creating a well-balanced group structure, with a focus on technological development, project management and productivity. This has contributed to stronger customer relations, advancement in our market positions and greater profitability.”

Operating profit in the company’s medical business increased by 11% year-on-year to SEK 191m. Sales in the business rose by 10% to SEK 1.46 bn. The company said that its focus on expanding partnerships with customers was received well in the market, resulting in higher activity.

Operating profit in the telecoms sector rose 37% to SEK 272m. Volumes were higher than anticipated in the fourth quarter. However, product changeovers will instead take place during the current quarter (Q1 2016), resulting in substantially lower volumes than in the fourth quarter of 2015, the company said. Sales in the business increased by 12% to SEK 2.02 bn. Adjusted for currency, sales decreased by 8%.

The company’s industrial business recorded a rise in operating profit of 12% to SEK 132m, as increased market share and continued investments in technology had a positive effect. Sales rose by 13% (11% adjusted for currency) to SEK 1.25 bn.